Published 11 September 2009, doi:10.1136/bmj.b3737
Cite this as: BMJ 2009;339:b3737

News

Doctors prescribe more drugs recommended by NICE than predicted

Helen Mooney

1 London

The first 150 words of the full text of this article appear below.

The influence of the National Institute for Health and Clinical Excellence (NICE) across the NHS is widespread with seven out of 12 drugs appraised by the agency being used at higher rates than previously forecast, a study from the NHS Information Centre has found.

According to Joe Collier, former adviser to the Commons Health Select Committee’s 2006 report on the role of NICE the findings are welcome.

"The Health Select Committee report recommended that NICE do more to extend their influence and these figures show for the first time that they have done that. This is an attractive change," he said.

Out of a range of drugs covering 13 NICE technology appraisals the report showed that uptake was higher than expected for seven types of drug and lower than expected for five others.

In the case of the drug natalizumab, which is used to treat multiple sclerosis, observed use was . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

The implementation of NICE Technology Appraisals: the experience at the patient level
Jonathan R Bayly, et al.
bmj.com, 16 Sep 2009 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ